BLUE : Insider Transactions for Bluebird Bio, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bluebird Bio, Inc. (BLUE)

$1.06

0.06 (5.36%) as of 4:30 Fri 5/10

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

139,126,000

Market Cap:

147.47(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.8871 - $4.83

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	17,438	35,533	57,514	116,582
Total Sell Value	$26,639	$61,294	$139,194	$443,003
Total People Sold	3	5	5	9
Total Sell Transactions	3	9	12	23
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 939

Page 20 of 38

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-08-28

4

OE

$5.50

$6,876

D/D

1,250

28,555

-

Maraganore John

Director

– • –

2017-08-24

4

S

$95.13

$1,062,108

D/D

(11,085)

8,597

-

Maraganore John

Director

– • –

2017-08-24

4

OE

$2.09

$28,924

D/D

13,839

19,682

-

Director

– • –

2017-08-14

4

S

$95.95

$95,950

D/D

(1,000)

1,000

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-08-10

4

AS

$95.41

$119,265

D/D

(1,250)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-08-10

4

OE

$5.50

$6,876

D/D

1,250

28,555

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-08-07

4

AS

$99.00

$74,250

D/D

(750)

30,484

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-08-07

4

OE

$50.51

$25,255

D/D

500

31,234

-

Principal Accounting Officer

• – –

2017-08-04

4

S

$95.21

$42,370

D/D

(445)

5,674

-

Principal Accounting Officer

• – –

2017-08-04

4

OE

$50.51

$23,890

D/D

445

6,119

-

Principal Accounting Officer

• – –

2017-08-03

4

S

$92.35

$38,418

D/D

(416)

5,674

-

Principal Accounting Officer

• – –

2017-08-03

4

OE

$20.70

$9,237

D/D

416

6,090

-

Maraganore John

Director

– • –

2017-08-02

4

S

$96.74

$266,425

D/D

(2,754)

5,843

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-08-01

4

AS

$92.83

$139,620

D/D

(1,500)

30,734

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-08-01

4

OE

$50.51

$37,883

D/D

750

32,234

-

Chief Medical Officer

• – –

2017-08-01

4

AS

$91.84

$277,099

D/D

(3,000)

15,977

-

Chief Medical Officer

• – –

2017-08-01

4

OE

$2.09

$6,270

D/D

3,000

18,977

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-07-10

4

AS

$99.88

$249,724

D/D

(2,500)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-07-10

4

OE

$5.50

$13,751

D/D

2,500

29,805

-

Chief Medical Officer

• – –

2017-07-07

4

AS

$100.43

$120,583

D/D

(1,200)

15,977

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-07-06

4

AS

$103.83

$233,616

D/D

(2,250)

31,484

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-07-06

4

OE

$50.51

$63,138

D/D

1,250

33,734

-

Chief Legal Officer

• – –

2017-07-06

4

OE

$22.53

$115,489

D/D

5,126

20,927

-

Chief Medical Officer

• – –

2017-07-05

4

AS

$105.26

$526,395

D/D

(5,000)

17,177

-

Chief Medical Officer

• – –

2017-07-05

4

OE

$2.09

$10,450

D/D

5,000

22,177

-

939 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 20 of 38

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.